Foley Represents Magellan Health in Kaden Health Investment

29 October 2020 Media Contact: Jill Chanen News

Foley & Lardner represented Magellan Health (NASDAG:MGLN) in a strategic equity investment in digital behavioral health company Kaden Health, Inc. Magellan’s investment will help Kaden scale access to its  proprietary services and platform in behavioral health services. The equity investment also will allow Kaden to integrate digital features into new models of behavioral healthcare and expand Magellan’s ability to offer disruptive, comprehensive and integrated complex care services and insights to members and clients.

The COVID-19 pandemic has heightened the need for virtual behavioral health solutions.

Magellan Health is a Fortune 500 company and a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology,  while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan’s customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators.

Partner Christopher Donovan led the Foley team along with Partners Paul Broude, Benjamin Dryden, Casey Fleming, Chanley Howell, Christopher McKenna, and John Palmer; Of Counsels Don Romano and Emily Wein; Senior Counsels Frederick Von Bryant and Hannah Zaitlin; Special Counsel Arthur Phillips; and Associates Sarah Field, Maxwell Harwitt and Sunny Levine.